News | April 25, 2025
We’re working at full force to put Bayer back on a profitable growth path: Bill Anderson, CEO, Bayer
Bayer expects 2025 to be the most difficult year of its turnaround
Bayer expects 2025 to be the most difficult year of its turnaround
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
The transaction is expected to be completed by May 15, 2025 or such other date as may be mutually agreed
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
The merged entity ‘Aster DM Quality Care’ will be jointly controlled by Aster Promoters and Blackstone
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
Subscribe To Our Newsletter & Stay Updated
